1. < Home

Pulmonary fibrosis

Cough in Fibrotic Interstitial Lung Disease: Effects and Implications

Channick JE, Swigris J. Cough in Fibrotic Interstitial Lung Disease: Effects and Implications. Am J Respir Crit Care Med. 2024 May 1. doi: 10.1164/rccm.202404-0683ED. Epub[...]

By sjmartinez • May 2, 2024
Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models

Li J, Xiao Y, Zhang Y, Li S, Zhao M, Xia T, Meng H. Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in[...]

By sjmartinez • August 4, 2023
COVID-19 Infection May Drive EC-like Myofibroblasts towards Myofibroblasts to Contribute to Pulmonary Fibrosis

Wu X, Zhang D, Boström KI, Yao Y. COVID-19 Infection May Drive EC-like Myofibroblasts towards Myofibroblasts to Contribute to Pulmonary Fibrosis. Int J Mol Sci.[...]

By sjmartinez • July 30, 2023
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton[...]

By sjmartinez • February 17, 2023
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects

Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler JHW, Alves M, Stock C, Distler O. Decline in forced vital capacity in subjects with systemic[...]

By sjmartinez • July 5, 2022